41.235 articles found

Beyond "Advanced": proposing Fluctuation-Dominant Parkinson's disease as a functional alternative to enable timely device-aided therapy.

Mittal SO, Jost WH.

J Neural Transm (Vienna) · 2026-06-02

DOI: 10.1007/s00702-026-03185-1PMID: 42228036

Polymeric lysosome-targeting chimeras for extracellular α-synuclein degradation in Parkinson's disease.

Bhattacharya A, Almohaimeed HM, Aggad WS, Almars AI, Altowaijri OMA, Waggas HA, Bauthman NM, Mohammedsaleh ZM, ALMatrafi TA, Saleh FM, Uti DE.

Acta Neuropathol Commun · 2026-06-02

DOI: 10.1186/s40478-026-02335-6PMID: 42231395

Herbal Neurotherapeutics for Cognitive Disorders: Integrative Mechanisms Linking Neurotransmitter Systems, Neurodegeneration, and the Gut-Brain Axis.

Rahman M, Akter K, Rani A, Park MN, Kim B.

Nutrients · 2026-06-02

DOI: 10.3390/nu18111796PMID: 42280440

The gut-brain axis in Alzheimer's and Parkinson's diseases: a systematic review of microbiota-derived biomarkers and novel therapeutic approaches.

Singh VK, Gupta P, Jain SK, Matreja PS.

J Clin Exp Neuropsychol · 2026-06-02

DOI: 10.1080/13803395.2026.2673084PMID: 42227044

Phytochemical engineered quantum dots as potential therapy to counter alpha synuclein aggregation in Parkinson's disease.

Shashwat P, Kirthi AV, Selvaraj M, Karnwal A, Dutta J.

Neurochem Int · 2026-06-02

DOI: 10.1016/j.neuint.2026.106194PMID: 42235756

Mirabegron and Intradetrusor Onabotulinumtoxina for Overactive Bladder in Parkinson's Disease: A Systematic Review and Meta-Analysis.

Arshad H, Nuha R, Khashaba S, Gillatt D, Lewis SJG.

Neurourol Urodyn · 2026-06-02

DOI: 10.1002/nau.70322PMID: 42226719

A Sensorimotor Framework for the Neurorehabilitation of Oculomotor Dysfunction in Parkinson’s Disease

Yap T.

Journal of clinical medicine · 2026-06-01

Progression in Parkinson's Disease.

Irmady K, Przedborski S.

Cold Spring Harb Perspect Med · 2026-06-01

DOI: 10.1101/cshperspect.a041641PMID: 39929733

Biologic Definition of Parkinson Disease: A Pivotal Role for Molecular Imaging.

Brendel M, Barthel H, Höglinger GU.

J Nucl Med · 2026-06-01

DOI: 10.2967/jnumed.125.271573PMID: 42020151

Investigating Disordered Eating Behaviours Among Individuals Living With Neurodegenerative Disease: A Scoping Review.

Buttifant E, Allogmanny S, Probst Y.

J Hum Nutr Diet · 2026-06-01

DOI: 10.1111/jhn.70250PMID: 42071322

Molecular Dialogues in the Mitochondria-Microbiome Crosstalk: Metabolites, Signaling, and Immunity.

Koynova-Tenchov R.

Compr Physiol · 2026-06-01

DOI: 10.1002/cph4.70164PMID: 42124488

New evidence on the clinical, genetic, and biochemical bases of GBA1-Parkinson's disease: prospects for treatment.

Menozzi E, Toffoli M, Deleidi M, Di Monte DA, Blandini F, Krainc D, Sidransky E, Schapira AHV.

Lancet Neurol · 2026-06-01

DOI: 10.1016/s1474-4422(26)00090-6PMID: 42127935